Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells

Blood

Volumn 96, Issue 12, 2000, Pages 3847-3856

  Maeda, T ^a   Towatari, M ^a   Kosugi, H ^a   Saito, H ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BUTYRIC ACID; CD86 ANTIGEN; CELL ADHESION MOLECULE; ENZYME INHIBITOR; FR 901228; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; HLA ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; TRAPOXIN A; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ACETYLATION; ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CELL STRAIN HL 60; CHROMATIN; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOTHERAPY; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL;

EID: 0034548836     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.12.3847     Document Type: Article

References (59)

1. Acute leukemia in adults
2. Medical progress: Acute myeloid leukemia
3. How does bone-marrow transplantation cure leukaemia?
4. Graft-versus-leukemia: No longer an epiphenomenon
5. A cell culture model for T lymphocyte clonal anergy
6. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy induction of productive immunity and down-regulation of the immune response
7. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
8. B70 antigen is a second ligand for CTLA-4 and CD28
9. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL
10. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1
11. Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo
12. Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation
13. Expression of costimulatory molecules in human leukemias
14. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition
15. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal
16. Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity
17. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells
18. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent
19. The CBP co-activator is a histone acetyltransferase
20. A positive role for histone acetylation in transcription factor access to nucleosomal DNA
21. Effects of sodium butyrate, a new pharmacological agent, on cells in culture
22. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
23. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
24. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase
25. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
26. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
27. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in Chromatin structure and function
28. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: A new approach to anti-leukemia therapy
29. Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells
30. Histone deacetylase inhibitors as potential anti-skin cancer agents
31. Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells
32. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders
33. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease
34. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
35. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation
36. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase
37. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
38. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes
39. Enhanced B7-2 gene expression by interferon-gamma in human monocytic cells is controlled through transcriptional and posttranscriptional mechanisms
40. Chromatin remodeling and leukemia: New therapeutic paradigms
41. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells
42. Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation
43. Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells
44. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 co-stimulatory molecules
45. Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory molecule
46. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 co-stimulatory molecules
47. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo
48. Importance of the B7-2 molecule for low dose melphalan-induced acquisition of tumor-eradicating immunity by mice bearing a large MOPC- 315 tumor
49. CD28/B7 system of T cell costimulation
50. T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC
51. A cell type-specific enhancer in the human B7.1 gene regulated by NF- kappaB
52. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter
53. Transcriptional activation by NF-kappaB requires multiple coactivators
54. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p
55. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3
56. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family
57. Three proteins define a class of human histone deacetylases related to yeast Hda1p
58. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression
59. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor